Form 4 for GILD Gilead Sciences
Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001127602-22-013724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-05-06 | 2022-05-05 | GILD | Lofton Kevin E | Dir | A - Grant | $0.00 | +2,444 | 95.2K | +3% | $0 |
| D | 2022-05-06 | 2022-05-05 | GILD | Lofton Kevin E | Dir | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-05 | A | A | 2,444 | $0.00 | 95,192 | I By Trust | — | — | (F1) Represents 2.444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022. (F2) Includes 65,874 shares held in a Revocable Living Trust and 29,318 shares held in a Grantor Retained Annuity Trust. |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2022-05-05 | A | A | 15,851 | $0.00 | 15,851 | D | $61.35 · — to 2032-05-05 | 15,851 Common Stock | (F3) 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. |